Literature DB >> 18427153

GPR119: "double-dipping" for better glycemic control.

L Lauffer1, R Iakoubov, P L Brubaker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18427153     DOI： 10.1210/en.2008-0182

Source DB:  PubMed          Journal:  Endocrinology        ISSN： 0013-7227            Impact factor:   4.736


× No keyword cloud information.
  17 in total

Review 1.  International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂.

Authors:  R G Pertwee; A C Howlett; M E Abood; S P H Alexander; V Di Marzo; M R Elphick; P J Greasley; H S Hansen; G Kunos; K Mackie; R Mechoulam; R A Ross
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

Review 2.  G protein-coupled receptors as targets for anti-diabetic therapeutics.

Authors:  Da Young Oh; Jerrold M Olefsky
Journal:  Nat Rev Drug Discov       Date:  2016-01-29       Impact factor: 84.694

Review 3.  Endocannabinoid signaling pathways: beyond CB1R and CB2R.

Authors:  Roger Gregory Biringer
Journal:  J Cell Commun Signal       Date:  2021-05-12       Impact factor: 5.782

4.  Identification of Novel, Structurally Diverse, Small Molecule Modulators of GPR119.

Authors:  Ainhoa Nieto; Virneliz Fernández-Vega; Timothy P Spicer; Emmanuel Sturchler; Pramisha Adhikari; Nicole Kennedy; Sean Mandat; Peter Chase; Louis Scampavia; Thomas Bannister; Peter Hodder; Patricia H McDonald
Journal:  Assay Drug Dev Technol       Date:  2018-07       Impact factor: 1.738

5.  A categorical structure-activity relationship analysis of GPR119 ligands.

Authors:  Pritesh Kumar; Carl A Carrasquer; Arren Carter; Zhao-Hui Song; Albert R Cunningham
Journal:  SAR QSAR Environ Res       Date:  2014       Impact factor: 3.000

6.  GPR119 Agonism Increases Glucagon Secretion During Insulin-Induced Hypoglycemia.

Authors:  Nina Xiaoyan Li; Stacey Brown; Tim Kowalski; Margaret Wu; Liming Yang; Ge Dai; Aleksandr Petrov; Yuyan Ding; Tamara Dlugos; Harold B Wood; Liangsu Wang; Mark Erion; Robert Sherwin; David E Kelley
Journal:  Diabetes       Date:  2018-04-18       Impact factor: 9.461

Review 7.  Trends in GPCR drug discovery: new agents, targets and indications.

Authors:  Alexander S Hauser; Misty M Attwood; Mathias Rask-Andersen; Helgi B Schiöth; David E Gloriam
Journal:  Nat Rev Drug Discov       Date:  2017-10-27       Impact factor: 84.694

8.  Molecular matchmaking between the popular weight-loss herb Hoodia gordonii and GPR119, a potential drug target for metabolic disorder.

Authors:  Shuyong Zhang; Yuyong Ma; Jing Li; Junjun Ma; Biao Yu; Xin Xie
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-22       Impact factor: 11.205

Review 9.  Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes.

Authors:  Bo Ahrén
Journal:  Nat Rev Drug Discov       Date:  2009-04-14       Impact factor: 84.694

10.  GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell.

Authors:  Lina M Lauffer; Roman Iakoubov; Patricia L Brubaker
Journal:  Diabetes       Date:  2009-02-10       Impact factor: 9.461
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.